Long-lived effector/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients

被引:95
|
作者
Yang, Li-Tao
Peng, Hui
Zhu, Zhao-Ling
Li, Gang
Huang, Zi-Tong
Zhao, Zhi-Xin
Koup, Richard A.
Bailer, Robert T.
Wu, Chang-You
机构
[1] Sun Yat Sen Univ, Zhongshan Med Sch, Dept Immunol, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 3, Guangzhou 510630, Peoples R China
[3] Sun Yat Sen Univ, Affiliated Hosp 2, Guangzhou 510120, Peoples R China
[4] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA
基金
中国国家自然科学基金;
关键词
SARS; SARS-CoV; S protein; IFN-gamma; cellular immune response; memory T cells;
D O I
10.1016/j.clim.2006.05.002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The role of cell-mediated immunity in human SARS-CoV infection is still not welt understood. In this study, we found that memory T-cell responses against the spike (S) protein were persistent for more than I year after SARS-CoV infection by detecting the production of IFN-gamma using ELISA and ELISpot assays. Flow cytometric analysis showed that both CD4(+) and CD8(+) Tcells were involved in cellular responses against SARS-CoV infection. Interestingly, most of SARS-CoV S-specific memory CD4(+) Tcells were central memory cells expressing CD45RO(+) CCR7(+) CD62L(-). However, the majority of memory CD8(+) Tcells revealed effector memory phenotype expressing CD45RO(-) CCR7(-) CD62L(-). Thus, our study provides the evidence that SARS-CoV infection in humans can induce cellular immune response that is persistent for a tong period of time. These data may have an important implication in the possibility of designing effective vaccine against SARS-CoV infection, specifically in defining T-cell populations that are implicated in protective immunity. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:171 / 178
页数:8
相关论文
共 50 条
  • [21] A comparative review of pathogenesis and host innate immunity evasion strategies among the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV)
    Noor, Rashed
    ARCHIVES OF MICROBIOLOGY, 2021, 203 (05) : 1943 - 1951
  • [22] The ORF7b protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is expressed in virus-infected cells and incorporated into SARS-CoV particles
    Schaecher, Scott R.
    Mackenzie, Jason M.
    Pekosz, Andrew
    JOURNAL OF VIROLOGY, 2007, 81 (02) : 718 - 731
  • [23] Investigation of the pharmacophore space of Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) NTPase/helicase by dihydroxychromone derivatives
    Lee, Chaewoon
    Lee, Jin Moo
    Lee, Na-Ra
    Kim, Dong-Eun
    Jeong, Yong-Joo
    Chong, Youhoon
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (16) : 4538 - 4541
  • [24] T-cell epitopes in Severe acute respiratory syndrome (SARS) coronavirus spike protein elicit a specific T-cell immune response in patients who recover from SARS
    Wang, YD
    Sin, WYF
    Xu, GB
    Yang, HH
    Wong, TY
    Pang, XW
    He, XY
    Zhang, HG
    Ng, JNL
    Cheng, CSS
    Lu, J
    Meng, L
    Yang, RF
    Lai, ST
    Guo, ZH
    Xie, Y
    Chen, WF
    JOURNAL OF VIROLOGY, 2004, 78 (11) : 5612 - 5618
  • [25] Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Central Nervous System
    De Felice, Fernanda G.
    Tovar-Moll, Fernanda
    Moll, Jorge
    Munoz, Douglas P.
    Ferreira, Sergio T.
    TRENDS IN NEUROSCIENCES, 2020, 43 (06) : 355 - 357
  • [26] Effects of the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV) on the nervous system. What can we expect from SARS-CoV-2?
    Monroy-Gomez, Jeison
    Torres-Fernandez, Orlando
    BIOMEDICA, 2020, 40 : 173 - 179
  • [27] Rewiring the severe acute respiratory syndrome coronavirus (SARS-CoV) transcription circuit: Engineering a recombination-resistant genome
    Yount, Boyd
    Roberts, Rhonda S.
    Lindesmith, Lisa
    Baric, Ralph S.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (33) : 12546 - 12551
  • [28] On Channel Activity of Synthetic Peptides Derived from Severe and Acute Respiratory Syndrome Coronavirus (SARS-CoV) E Protein
    Verdia Baguena, Carmina
    Nieto-Torres, Jose L.
    Alcaraz, Antonio
    DeDiego, Marta L.
    Enjuanes, Luis
    Aguilella, Vicente M.
    BIOPHYSICAL JOURNAL, 2012, 102 (03) : 656A - 657A
  • [29] Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice
    Glass, WG
    Subbarao, K
    Murphy, B
    Murphy, PM
    JOURNAL OF IMMUNOLOGY, 2004, 173 (06): : 4030 - 4039
  • [30] Comparison of immunogylobulin G responses to the spike and nucleocapsid proteins of severe acute respiratory syndrome (SARS) coronavirus in patients with SARS
    Zhao, Jincun
    Wang, Wei
    Wang, Wenling
    Zhao, Zhendong
    Zhang, Yan
    Lv, Ping
    Ren, Furong
    Gao, Xiao-Ming
    CLINICAL AND VACCINE IMMUNOLOGY, 2007, 14 (07) : 839 - 846